Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Nebivolol 2.5 mg + Cilnidipine 10 mg Tablet
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
This tablet combines two medicines to help control high blood pressure (hypertension). Nebivolol is a beta-blocker that slows the heart rate and reduces the heart’s workload, while Cilnidipine is a calcium channel blocker that relaxes blood vessels and improves blood flow. Together, they effectively lower blood pressure, protect the heart and blood vessels, and reduce the risk of heart attack, stroke, and kidney damage. The 2.5 mg Nebivolol dose is a milder option, often used for patients who need gentle blood pressure control.
Common side effects include dizziness, headache, swelling of ankles or feet, slow heartbeat, flushing, and tiredness. Rarely, it may cause very low blood pressure, shortness of breath, or allergic reactions.
Used to manage high blood pressure and reduce long-term complications of hypertension, such as heart disease and stroke.
Take this medicine exactly as prescribed by your doctor. Do not stop suddenly, as it can cause a sudden rise in blood pressure. Inform your doctor if you have heart rhythm problems, kidney or liver disease, or if you are pregnant or breastfeeding. Avoid alcohol, as it can increase dizziness or lower blood pressure further.
Store in a cool, dry place below 30°C, away from sunlight and moisture. Keep out of reach of children and use before the expiry date.
Composition : Nebivolol 2.5 mg Tablet
Composition : Nebivolol 5 mg Tablet
Composition : Telmisartan 40 mg + Nebivolol 5 mg Tablet
Composition : Nebivolol 5 mg + Amlodipine 5 mg Tablet
Composition : Nebivolol 5 mg + Hydrochlorothiazide 12.5 mg Tablet
Composition : Nebivolol 5 mg + Cilnidipine 10 mg Tablet
Composition : Nebivolol 2.5 mg + Cilnidipine 10 mg Tablet
Composition : Nicorandil 10 mg Tablet
Composition : Nicorandil (5mg) Tablet
Composition : Olmesartan 20 mg + Hydrochlorothiazide 12.50 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Nebivolol 2.5 mg + Cilnidipine 10 mg Tablet is a combination antihypertensive medication used for the management of high blood pressure (hypertension) and associated cardiovascular disorders. Nebivolol is a beta-blocker that helps regulate heart rate and reduce cardiac workload, while Cilnidipine is a calcium channel blocker that relaxes blood vessels and improves blood circulation. This combination is widely prescribed in the cardiac and cardiovascular care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and healthcare clinics. With the rising prevalence of hypertension and the growing preference for combination therapies, this product offers steady prescription demand, repeat orders, and long-term market potential.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiac and cardiovascular segment with monopoly rights, quality-assured manufacturing, promotional support, and dependable product availability for distributors and franchise partners.
Wholesalers and distributors benefit from strong prescription volume, increasing cardiovascular healthcare demand, long-term patient usage, and repeat sales opportunities, making this product a profitable and sustainable addition to their pharmaceutical portfolio when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiac and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiovascular care segment.